Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar-Apr;45(2):104-111.
doi: 10.5144/0256-4947.2025.104. Epub 2025 Apr 3.

Association between human herpesviruses and head and neck squamous cell carcinoma: a molecular perspective

Affiliations

Association between human herpesviruses and head and neck squamous cell carcinoma: a molecular perspective

Merve Gürler et al. Ann Saudi Med. 2025 Mar-Apr.

Abstract

Background: Head and neck cancer (HNC) is the seventh most common malignant tumor. Herpesviruses are a significant risk factor in the multifactorial pathogenesis of HNC.

Objectives: This study aimed to investigate the association between herpesviruses and the development of head and neck squamous cell carcinoma (HN-SCC).

Design: Experimental study.

Setting: A university hospital in Turkey.

Patients and methods: Pathological archive tissue samples of 500 patients were included in the study. These samples were categorized into two groups: those diagnosed with HN-SCC (n=300, malignant group [MG]) and those diagnosed with benign head and neck lesions (n=200, benign group [BG]). The presence of herpesvirus in samples was detected using polymerase chain reaction.

Main outcome measures: Association of herpesviruses in the development of head and neck cancer.

Sample size: 500 patients.

Results: HHV-1, -2, -7, and -8 were not detected in any samples. In the malignant group (MG), EBV-DNA was detected in 1 patient (0.3%) and HHV-6 DNA in 2 patients (0.6%), while in the benign group (BG), VZV-DNA was detected in 1 patient (0.5%), EBV-DNA in 3 patients (1.5%), CMV-DNA in 5 patients (2.5%), and HHV-6 DNA in 3 patients (1.5%). While no significant difference was found between the groups for VZV, EBV, and HHV-6, a statistically significant difference was found in favor of the benign group for CMV.

Conclusion: Although herpesvirus seroprevalence is relatively high in the population, the lack of viral genome in tissue samples indicates that other factors might be prominent in developing HN-SCC.

Limitation: The storage conditions of the sample used (paraffinized sample) may have negatively affected the detection frequency of HHVs.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST: None.

Figures

Figure 1.
Figure 1.
Agarose gel electrophoresis of PCR products with primer of the EBV DNA. Ultra GelRed Nucleic AcidStain (10000x) (GR501-01) (Vazyme, China) was used for staining agarose gel electrophoresis. M: Molecular size marker (Gene Ruler DNA Ladder, 50–500 bp, Thermo, Germany), NC: Negative control, 1–4: Patient isolates, PC: Positive control.
Figure 2.
Figure 2.
Agarose gel electrophoresis of PCR products with primer of the VZV DNA. Ultra GelRed Nucleic AcidStain (10000x) (GR501-01) (Vazyme, China) was used for staining agarose gel electrophoresis. M: Molecular size marker (Gene Ruler DNA Ladder, 50–500 bp, Thermo, Germany), NC: Negative control, 1: Patient isolates, PC: Positive control.
Figure 3.
Figure 3.
Agarose gel electrophoresis of PCR products with primer of the CMV DNA. Ultra GelRed Nucleic AcidStain (10000x) (GR501-01) (Vazyme, China) was used for staining agarose gel electrophoresis. M: Molecular size marker (Gene Ruler DNA Ladder, 50–500 bp, Thermo, Germany), NC: Negative control, 1–5: Patient isolates, PC: Positive control.
Figure 4.
Figure 4.
Agarose gel electrophoresis of PCR products with primer of the HHV-6 DNA. Ultra GelRed Nucleic AcidStain (10000x) (GR501-01) (Vazyme, China) was used for staining agarose gel electrophoresis. M: Molecular size marker (Gene Ruler DNA Ladder, 50–500 bp, Thermo, Germany), NC: Negative control, 1–5: Patient isolates, PC: Positive control.

Similar articles

References

    1. Goon P, Schürmann M, Oppel F, Shao S, Schleyer S, Pfeiffer CJ, et al. .. Viral and clinical oncology of head and neck cancers. Current Oncology Reports. 2022;24(7):929–42. - PMC - PubMed
    1. Wołącewicz M, Becht R, Grywalska E, Niedźwiedzka-Rystwej P. Herpesviruses in head and neck cancers. Viruses. 2020;12(2):172. - PMC - PubMed
    1. Samara P, Athanasopoulos M, Mastronikolis S, Kyrodimos E, Athanasopoulos I, Mastronikolis NS. The Role of Oncogenic Viruses in Head and Neck Cancers: Epidemiology, Pathogenesis, and Advancements in Detection Methods. Microorganisms. 2024;12(7):1482. - PMC - PubMed
    1. Carlander A-LF, Larsen CG, Jensen DH, Garnæs E, Kiss K, Andersen L, et al. .. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014. European Journal of Cancer. 2017;70:75–82. - PubMed
    1. She Y, Nong X, Zhang M, Wang M. Epstein-Barr virus infection and oral squamous cell carcinoma risk: A meta-analysis. PLoS One. 2017;12(10):e0186860. - PMC - PubMed

MeSH terms

LinkOut - more resources